Cargando…

Variation in MSRA Modifies Risk of Neonatal Intestinal Obstruction in Cystic Fibrosis

Meconium ileus (MI), a life-threatening intestinal obstruction due to meconium with abnormal protein content, occurs in approximately 15 percent of neonates with cystic fibrosis (CF). Analysis of twins with CF demonstrates that MI is a highly heritable trait, indicating that genetic modifiers are la...

Descripción completa

Detalles Bibliográficos
Autores principales:	Henderson, Lindsay B., Doshi, Vishal K., Blackman, Scott M., Naughton, Kathleen M., Pace, Rhonda G., Moskovitz, Jackob, Knowles, Michael R., Durie, Peter R., Drumm, Mitchell L., Cutting, Garry R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3305406/ https://www.ncbi.nlm.nih.gov/pubmed/22438829 http://dx.doi.org/10.1371/journal.pgen.1002580

Ejemplares similares

Genetic Modifiers of Cystic Fibrosis–Related Diabetes
por: Blackman, Scott M., et al.
Publicado: (2013)

Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis
por: Sun, Lei, et al.
Publicado: (2012)

The Antioxidant Enzyme Methionine Sulfoxide Reductase A (MsrA) Interacts with Jab1/CSN5 and Regulates Its Function
por: Jiang, Beichen, et al.
Publicado: (2020)

Methionine Sulfoxide Reductase A (MsrA) and Its Function in Ubiquitin-Like Protein Modification in Archaea
por: Fu, Xian, et al.
Publicado: (2017)

Novel variation at chr11p13 associated with cystic fibrosis lung disease severity
por: Dang, Hong, et al.
Publicado: (2016)

Corrigendum: Novel variation at chr11p13 associated with cystic fibrosis lung disease severity
por: Dang, Hong, et al.
Publicado: (2017)

Deep resequencing of CFTR in 762 F508del homozygotes reveals clusters of non-coding variants associated with cystic fibrosis disease traits
por: Vecchio-Pagán, Briana, et al.
Publicado: (2016)

Genome-wide association and linkage identify modifier loci of lung disease severity in cystic fibrosis at 11p13 and 20q13.2
por: Wright, Fred A., et al.
Publicado: (2011)

Improving imputation in disease-relevant regions: lessons from cystic fibrosis
por: Panjwani, Naim, et al.
Publicado: (2018)

Mining GWAS and eQTL data for CF lung disease modifiers by gene expression imputation
por: Dang, Hong, et al.
Publicado: (2020)

Analysis of a large cohort of cystic fibrosis patients with severe liver disease indicates lung function decline does not significantly differ from that of the general cystic fibrosis population
por: Polineni, Deepika, et al.
Publicado: (2018)

Genome-wide association meta-analysis identifies five modifier loci of lung disease severity in cystic fibrosis
por: Corvol, Harriet, et al.
Publicado: (2015)

Self-reported exercise and longitudinal outcomes in cystic fibrosis: a retrospective cohort study
por: Collaco, Joseph M, et al.
Publicado: (2014)

Deletion of mouse MsrA results in HBO-induced cataract: MsrA repairs mitochondrial cytochrome c
por: Brennan, LA, et al.
Publicado: (2009)

Mutations that permit residual CFTR function delay acquisition of multiple respiratory pathogens in CF patients
por: Green, Deanna M, et al.
Publicado: (2010)

Histo-Blood Group Gene Polymorphisms as Potential Genetic Modifiers of Infection and Cystic Fibrosis Lung Disease Severity
por: Taylor-Cousar, Jennifer L., et al.
Publicado: (2009)

Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci
por: Gong, Jiafen, et al.
Publicado: (2019)

Replication and characterization of CADM2 and MSRA genes on human behavior
por: Boutwell, Brian, et al.
Publicado: (2017)

Modifier genes and variation in cystic fibrosis
por: Drumm, Mitchell L
Publicado: (2001)

IFRD1 polymorphisms in cystic fibrosis with potential link to altered neutrophil function
por: Gu, YuanYuan, et al.
Publicado: (2009)

Mucin Variable Number Tandem Repeat Polymorphisms and Severity of Cystic Fibrosis Lung Disease: Significant Association with MUC5AC
por: Guo, XueLiang, et al.
Publicado: (2011)

The Functions of the Mammalian Methionine Sulfoxide Reductase System and Related Diseases
por: Jiang, Beichen, et al.
Publicado: (2018)

Leveraging TOPMed imputation server and constructing a cohort-specific imputation reference panel to enhance genotype imputation among cystic fibrosis patients
por: Sun, Quan, et al.
Publicado: (2022)

Selenium and the Methionine Sulfoxide Reductase System
por: Oien, Derek B., et al.
Publicado: (2009)

KRAS, YWHAE, SP1 and MSRA as biomarkers in endometrial cancer
por: Yang, Ye, et al.
Publicado: (2021)

Genetic Influences on Cystic Fibrosis Lung Disease Severity
por: Weiler, Colleen A., et al.
Publicado: (2013)

Validation of the Thai version of SARC-F, MSRA-7, and MSRA-5 questionnaires compared to AWGS 2019 and sarcopenia risks in older patients at a medical outpatient clinic
por: Akarapornkrailert, Phuriwat, et al.
Publicado: (2020)

A symbiotic supramolecular approach to the design of novel amphiphiles with antibacterial properties against MSRA
por: Tyuleva, Stilyana N., et al.
Publicado: (2019)

Decreased Phosphorylation and Increased Methionine Oxidation of α-Synuclein in the Methionine Sulfoxide Reductase A Knockout Mouse
por: Oien, Derek B., et al.
Publicado: (2011)

Erratum to “Decreased Phosphorylation and Increased Methionine Oxidation of α-Synuclein in the Methionine Sulfoxide Reductase A Knockout Mouse”
por: Oien, Derek B., et al.
Publicado: (2012)

Accounting for population structure in genetic studies of cystic fibrosis
por: Kingston, Hanley, et al.
Publicado: (2022)

Protective Effects against the Development of Alzheimer’s Disease in an Animal Model through Active Immunization with Methionine-Sulfoxide Rich Protein Antigen
por: Smith, Adam S., et al.
Publicado: (2022)

The microbiome in pediatric cystic fibrosis patients: the role of shared environment suggests a window of intervention
por: Hampton, Thomas H, et al.
Publicado: (2014)

Luteolin increases susceptibility to macrolides by inhibiting MsrA efflux pump in Trueperella pyogenes
por: Guo, Yuru, et al.
Publicado: (2022)

Characterizing Mucociliary Clearance in Young Children with Cystic Fibrosis
por: Laube, Beth L., et al.
Publicado: (2022)

Structural and kinetic analysis of an MsrA–MsrB fusion protein from Streptococcus pneumoniae
por: Kim, Young Kwan, et al.
Publicado: (2009)

PEP-1-MsrA ameliorates inflammation and reduces atherosclerosis in apolipoprotein E deficient mice
por: Wu, Yao, et al.
Publicado: (2015)

Ferulic acid derivatives inhibiting Staphylococcus aureus tetK and MsrA efflux pumps
por: Pinheiro, Patrícia Gonçalves, et al.
Publicado: (2022)

Sarcopenia screening in elderly with Alzheimer’s disease: performances of the SARC-F-3 and MSRA-5 questionnaires
por: Bramato, Giulia, et al.
Publicado: (2022)

MsrA Overexpression Targeted to the Mitochondria, but Not Cytosol, Preserves Insulin Sensitivity in Diet-Induced Obese Mice
por: Hunnicut, JennaLynn, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g26tbv40kmst6srmhi414cqoo2